Literature DB >> 15363561

Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas.

Attila Varga1, Gabriella Czifra, Béla Tállai, Tamás Németh, Ilona Kovács, László Kovács, Tamás Bíró.   

Abstract

OBJECTIVES: Members of the protein kinase C (PKC) isoenzyme family play central role in the tumorigenesis of several tissues. In this study our goal was to determine the possible alterations in the protein kinase C (PKC) isoform pattern in relation with the different tumor grade in human urinary bladder carcinomas.
METHODS: Western blot analysis, followed by quantitative densitometry, was performed to define the expression of PKC isoforms in the epithelial tissue of human urinary bladder carcinomas with various tumor grades and in control samples.
RESULTS: The human urinary bladder epithelium expressed five PKC isoforms (PKC alpha, beta, delta, zeta), the levels of which differentially altered as a function of tumor grade. Namely, whereas the expressions of PKC beta and delta decreased with increasing grade of the carcinomas, the levels of PKC alpha, and zeta showed opposite patterns of changes.
CONCLUSIONS: These grade-dependent alterations in the PKC isoform pattern strongly argue for the central yet antagonistic roles of certain members of the PKC system in malignant transformation of human urinary bladder epithelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363561     DOI: 10.1016/j.eururo.2004.04.014

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  24 in total

1.  Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease.

Authors:  Huajun Jin; Arthi Kanthasamy; Dilshan S Harischandra; Naveen Kondru; Anamitra Ghosh; Nikhil Panicker; Vellareddy Anantharam; Ajay Rana; Anumantha G Kanthasamy
Journal:  J Biol Chem       Date:  2014-10-23       Impact factor: 5.157

Review 2.  Protein kinase C: perfectly balanced.

Authors:  Alexandra C Newton
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04       Impact factor: 8.250

3.  Inhibition of PKCα reduces the ability of migration of kidney cancer cells but has no impact on cell apoptosis.

Authors:  Bo Zhan; Chuize Kong; Zhe Zhang; Xiao Dong; Naiwen Zhang
Journal:  Exp Ther Med       Date:  2017-03-23       Impact factor: 2.447

4.  Expression of protein kinase C family in human hepatocellular carcinoma.

Authors:  Hsiu-Chin Lu; Fen-Pi Chou; Kun-Tu Yeh; Ya-Sian Chang; Nicholas C Hsu; Jan-Gowth Chang
Journal:  Pathol Oncol Res       Date:  2009-12-01       Impact factor: 3.201

5.  Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer.

Authors:  B L Allen-Petersen; C J Carter; A M Ohm; M E Reyland
Journal:  Oncogene       Date:  2013-03-11       Impact factor: 9.867

Review 6.  Dynamics and Membrane Interactions of Protein Kinase C.

Authors:  Tatyana I Igumenova
Journal:  Biochemistry       Date:  2015-08-05       Impact factor: 3.162

7.  Protein kinase C-dependent control of Bcl-x alternative splicing.

Authors:  Timothée Revil; Johanne Toutant; Lulzim Shkreta; Daniel Garneau; Philippe Cloutier; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

8.  Loss of protein kinase C delta gene expression in human squamous cell carcinomas: a laser capture microdissection study.

Authors:  Vipin Yadav; Nicole C Yanez; Sarah E Fenton; Mitchell F Denning
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

Review 9.  Reversing the Paradigm: Protein Kinase C as a Tumor Suppressor.

Authors:  Alexandra C Newton; John Brognard
Journal:  Trends Pharmacol Sci       Date:  2017-03-08       Impact factor: 14.819

Review 10.  Protein kinase Calpha: disease regulator and therapeutic target.

Authors:  Olga Konopatskaya; Alastair W Poole
Journal:  Trends Pharmacol Sci       Date:  2009-12-05       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.